Page last updated: 2024-11-07

spironolactone and Anosmia

spironolactone has been researched along with Anosmia in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Anosmia: Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Edwards, C1
Klekot, O1
Halugan, L1
Korchev, Y1

Other Studies

1 other study available for spironolactone and Anosmia

ArticleYear
Follow Your Nose: A Key Clue to Understanding and Treating COVID-19.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Adenosine Triphosphate; Adult; Aged; Angiopoietin-2; Angiotensin-Converting Enzyme 2; Animals; Anosm

2021